Home > Insider Trading > Filing (0001571049-15-006092)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1069899	Phibro Animal Health Corp	PAHC	Pharmaceutical Preparations (2834)	131840497

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1241560	Jack Bendheim	300 Frank W. Burr Blvd., Ste 21 Teaneck NJ 077666	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2015-07-29	18,000	$0.00	84,000	No	4	C	Indirect	See
Class A Common Stock	Disposition	2015-07-29	6,000	$37.01	78,000	No	4	S	Indirect	See
Class A Common Stock	Disposition	2015-07-30	6,000	$38.01	72,000	No	4	S	Indirect	See
Class A Common Stock	Disposition	2015-07-31	8,807	$39.58	63,193	No	4	S	Indirect	See

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See
No	4	S	Indirect	See
No	4	S	Indirect	See
No	4	S	Indirect	See

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Class B Common Stock	Disposition	2015-07-29	18,000	$0.00	18,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,247,275			No	4	C	Indirect

Footnotes

The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis, and had no expiration date.
The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI Co., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC on March 16, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.57 to $37.38, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.69 to $39.14, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.74 to $40.02, inclusive.